Quantcast The Pharmaceutical Holdr (PPH) Poised For Breakout
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

Morpheus Trading

Major Market and ETF Trading

The Pharmaceutical Holdr (PPH) Poised For Breakout

Posted on 12/03/2007 11:08:36 | Link | Post Comment


NOTE: Please click on the charts below to enlarge them if they do not appear clearly.

Stocks gapped higher out of the starting gate last Friday morning, but resistance of the S&P 500's 200-day moving average immediately reversed the opening momentum. The major indices subsequently drifted gently lower throughout the day before finishing with mixed results. Despite giving up about half of its opening gain, the S&P 500 still ticked 0.8% higher. The Dow Jones Industrial Average similarly gained 0.5%. The small-cap Russell 2000 and S&P Midcap 400 indices rallied 0.2% and 0.7% respectively. Each of the main stock market indexes closed in the bottom third to half of their intraday ranges.



Turnover swelled across the board, causing the Nasdaq Composite to register a bearish "distribution day." Total volume in the Nasdaq grew by 17%, while volume in the NYSE surged 40% above the previous day's level. The higher volume gain in the S&P technically counted as a bullish "accumulation day," but the weak intraday price pattern more closely resembled selling into strength than institutional buying. Advancing volume in the NYSE exceeded declining volume by nearly 3 to 1, a firmly positive spread. The Nasdaq adv/dec volume ratio was negative, but only by a margin of 3 to 2.



The U.S. dollar finally began to strengthen last week, causing a pullback in the CurrencyShares Euro Trust (FXE), which mirrors the price of the euro/dollar. For the first time since the current parabolic uptrend began in early September 2007, FXE closed below support of its 20-day EMA. This means we may see further strength in the dollar this week, which could lead to FXE correcting down to support of its 50-day MA. The daily chart of FXE below is a great example of how well the 20-day EMA provides support in steadily trending stocks and ETFs. Until last Friday, notice how every touch of the 20-day EMA immediately led to a resumption of the strong uptrend:





Advanced traders capable of managing quick short sales may consider a trade to take advantage of near-term downward momentum in FXE. However, whenever a stock or ETF is trading above its 50-day MA, upward reversals in the direction of the primary trend can be sudden and swift.



In last Friday's commentary, we discussed the relative strength in the Biotech Index ($BTK), as well as a few of the Biotech ETFs. On a similar note, we've noticed a lot of relative strength in the broader healthcare sector, as well as the primarily large-cap Pharmaceutical Index ($DRG). While the major indices are still well off their October highs, the Pharmaceutical HOLDR (PPH) has already recovered back to test its October high. A rally above last Friday's high will cause PPH to break out above its prior high, triggering a potential buy entry for at least a short-term trade. The target would be resistance of the 52-week high, which was set back in May. The setup is illustrated on the weekly chart of PPH below:





Now that the Fed has given the impression of another rate cut at its December 11 meeting, it will be interesting to see how well the market retains last week's gains. Recent interest rate cuts have generated positive knee-jerk reactions in the market that quickly faded. Given last week's impressive bounce off the lows and rally into key resistance levels, a mild pullback this week would not surprising. But in order for the current rally attempt to have legs, the major indices should not retrace more than about one-third to one-half of last week's gains. If a retracement deeper than 50% occurs, overall momentum could quickly shift back to the downside. We approach the new week with a slightly bullish near-term bias, keeping in mind that the long-term downtrends remain intact.




Open ETF positions:


Long - IDU

Short - (none)




NOTE: Regular subscribers to The Wagner Daily receive daily updates on the open positions above, as well as new ETF trade setups, including trigger, stop, and target prices. Intraday e-mail alerts are also sent on as-needed basis.





Deron Wagner is the head trader of Morpheus Capital Hedge Fund and founder of Morpheus Trading Group (morpheustrading.com), which he launched in 2001. Wagner appears on his best-selling video, Sector Trading Strategies (Marketplace Books, June 2002), and is co-author of both The Long-Term Day Trader (Career Press, April 2000) and The After-Hours Trader (McGraw Hill, August 2000). Past television appearances include CNBC, ABC, and Yahoo! FinanceVision. He is also a frequent guest speaker at various trading and financial conferences around the world. Wagner is currently working on this third book, scheduled for publication in early 2008.





For a free trial to the full version of The Wagner Daily above, which includes detailed ETF trade setups and daily position updates, or to learn about our other newsletters, visit morpheustrading.com or send an e-mail to deron@morpheustrading.com.


Stock Quote or
Examples
ATM Wallstreet - Mon Oct 06, 2008 03:39PM
Made several great trades today. Traded the QID, QQ [read more]
ATM Wallstreet - Tue Oct 07, 2008 10:07PM
Today we have the Fed speaking and release of Fed mi [read more]
Morpheus Trading - Tue Oct 07, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.